Inflammation treatment may help curb obesity, type 2 diabetes

07/10/2013 | American City Business Journals

Researchers at the University of Georgia's College of Pharmacy have successfully tested several anti-inflammatory compounds in mice that prevented weight gain and reduced the incidence of obesity-related conditions that can lead to type 2 diabetes. In one case, scientists injected mice with a plant pigment called rutin found in fruits and vegetables; in another, the mice were injected with interleukin 10. Both treatments controlled weight, reduced inflammation and prevented early signs of liver disease and diabetes.

View Full Article in:

American City Business Journals

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations
Vice President of Regulatory Affairs
Pentec Health
Boothwyn, PA
Sr Coordinator Clinical Research (US/TA/00/0073/SL) - 1400000AQX
Abbott
Santa Clara, CA
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA